These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2765132)

  • 1. In vitro sensitivity of Candida (Torulopsis) glabrata to clotrimazole.
    Fagnant JE; Clark RB; Monif GR
    Am J Reprod Immunol; 1989 Jan; 19(1):38-40. PubMed ID: 2765132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.
    Shadomy S; Dixon DM; May R
    Sabouraudia; 1982 Dec; 20(4):313-23. PubMed ID: 7157107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
    Yamaguchi H; Hiratani T; Plempel M
    Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of clotrimazole for Candida strains isolated from recent patient samples.
    Schmidt A
    Arzneimittelforschung; 1995 Dec; 45(12):1338-40. PubMed ID: 8595097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
    Barug D; Bastiaanse HB
    Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.
    Torres-Rodríguez JM; Mendez R; López-Jodra O; Morera Y; Espasa M; Jimenez T; Lagunas C
    Antimicrob Agents Chemother; 1999 May; 43(5):1258-9. PubMed ID: 10223946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Oct; 134(4):336-41. PubMed ID: 789787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
    Guinet R
    Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
    Mallié M; Montès B; Lebecq JC; Bastide JM
    Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole.
    Berg D; Regel E; Harenberg HE; Plempel M
    Arzneimittelforschung; 1984; 34(2):139-46. PubMed ID: 6372801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disk agar diffusion susceptibility testing of yeasts.
    Saubolle MA; Hoeprich PD
    Antimicrob Agents Chemother; 1978 Oct; 14(4):517-30. PubMed ID: 568910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of two benzofuran-imidazoles in different experimental conditions.
    Bellotti MG; Dubini F; Riviera L; Pestellini V
    J Chemother; 1991 Oct; 3(5):295-304. PubMed ID: 1809809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of strains of Candida albicans to jaritin, haloprogin, clotrimazole and miconazole.
    Langsadl L; Jedlickova Z
    Postgrad Med J; 1979 Sep; 55(647):695-6. PubMed ID: 392487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin].
    Suárez VL; Fernández Andreu CM
    Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
    Mallié M; Montès B; Reynes J; Bastide JM
    Drugs Exp Clin Res; 1990; 16(10):509-13. PubMed ID: 2100733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Torulopsis glabrata. Morphologic characteristics, biotyping and sensitivity to isolates of antifungal agents in vitro].
    Pospisil J
    Cesk Epidemiol Mikrobiol Imunol; 1991 Jan; 40(1):43-8. PubMed ID: 1826472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
    Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
    Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.